Cascade Cryobank
Cascade Cryobank is a Washington-state-based FDA-registered sperm bank founded in 2022 and now a subsidiary of Fertio (European Sperm Bank's parent). It sells five cryopreserved donor sperm vial types direct-to-consumer and to fertility clinics across the U.S. and Canada, differentiated by its Early Disclosure Program and 714-condition genetic screening.
- Company typePrivate
- Founded2022
- HeadquartersLynnwood, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Cascade Cryobank does
Cascade Cryobank is a Washington-state-based for-profit sperm bank founded in 2022 (per company history) and headquartered in Lynnwood, WA, operating as a wholly-owned subsidiary of Fertio, the international fertility care group that owns European Sperm Bank, following Fertio's March 2026 acquisition. The company recruits and screens sperm donors against an industry-rigorous bar — only about 4% of applicants are accepted — and processes donations through FDA-registered, CLIA-certified cryopreservation workflows meeting 21 CFR Part 1271, with state-level tissue bank licensure in Washington, New York, California, Colorado, Oregon, and Maryland, plus Health Canada Primary Establishment registration for cross-border distribution. Its core products are five cryopreserved vial types (IUI, ICI, IUI A.R.T., ICI A.R.T., and IVF/ICSI) sold direct-to-consumer via cascadecryobank.com, each with guaranteed post-thaw motile cell counts (e.g., $1,400-$2,300 per vial), supported by temperature-controlled FedEx shipping, optional long-term storage, and a CapexMD financing partnership.
The company's principal point of differentiation is the proprietary Early Disclosure Program, a first-of-its-kind identity-release framework that permits parents to access donor identifying information (name, date of birth, last known state) immediately after live birth reporting rather than at the donor-conceived child's 18th birthday, with counselor-facilitated meetings between donors and parents. Genetic depth is a second differentiator: each donor is screened against 714 recessive genetic conditions, including the seven recommended carrier conditions (SMA, sickle cell, alpha/beta thalassemia, Tay-Sachs, cystic fibrosis, fragile X), along with karyotype analysis and a four-generation family medical history.
Cascade Cryobank serves four primary customer segments — single parents by choice, LGBTQ+ individuals and couples, heterosexual couples facing male-factor infertility, and fertility clinics/reproductive healthcare providers — distributed through a hybrid DTC e-commerce plus B2B clinic coordination model. Geographic reach is anchored in the Pacific Northwest (Lynnwood HQ, with named service areas in Seattle, Portland, and Boise) but vials are shipped nationwide and now into Canada. Leadership combines founder/Medical Director Dr. John Carpenter (board-certified pathologist, Seattle-area practice since 2010) and COO Corey Burke (25+ years in reproductive health, prior EVP at Cryos International, contributed to 3,000+ births, 25+ FDA inspections led).
Cascade Cryobank firmographics
Firmographics- Name
- Cascade Cryobank
- Legal name
- Cascade Cryobank LLC
- Website
- https://cascadecryobank.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cascade Cryobank is a Washington-state-based FDA-registered sperm bank founded in 2022 and now a subsidiary of Fertio (European Sperm Bank's parent). It sells five cryopreserved donor sperm vial types direct-to-consumer and to fertility clinics across the U.S. and Canada, differentiated by its Early Disclosure Program and 714-condition genetic screening.
- Ownership category
- akta.pro rank
Cascade Cryobank industry classification
Industry- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)
- akta.pro secondary industry
- Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)
Keywords
Where Cascade Cryobank is headquartered
LocationHeadquarters
- HQ city
- Lynnwood
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Cascade Cryobank business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Donor Sperm Vial Sales: Primary revenue from selling cryopreserved donor sperm vials. Different vial types available: IUI (washed), ICI (unprocessed), IUI A.R.T., ICI A.R.T., and IVF/ICSI vials. Pricing varies by disclosure type (Open ID vs Early Disclosure) and cell count specifications.
- Specimen Storage: Long-term cold storage of purchased sperm vials. Free storage promotion offered with purchase of 2+ vials (number of vials + 2 additional months free). Storage fees apply after free period.
- Shipping and Delivery: Revenue from shipping specimens via FedEx in dry shippers. Standard continental US shipping $300 (2-day, Mon-Wed only), overnight priority $395 (Mon-Fri, delivery by noon). International and Alaska/Hawaii shipping available at higher rates.
- Sperm Donation Compensation: Donors receive compensation: $40 per initial test donation, $125 per accepted donation ($50 at time of donation, $50 after freeze/thaw test, $25 after 6-month quarantine clearance). Monthly earnings can reach up to $1,400 with bonuses. Donors earning $600+/year receive 1099 tax forms.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | IUI 10 Open ID - Washed specimens for insemination procedures with 10+ million motile cells |
| Unit Pricing | Pay-as-you-go | IUI 10 Early Disclosure - Premium identity disclosure option with same specifications |
| Unit Pricing | Pay-as-you-go | IUI A.R.T. - Cost-effective option for lower cell count requirements |
| Unit Pricing | Pay-as-you-go | ICI A.R.T. - Unprocessed specimens for ICI or IUI/IVF with medical processing |
| Unit Pricing | Pay-as-you-go | IVF/ICSI - Specimens for ICSI procedures |
| Unit Pricing | Pay-as-you-go | Continental US Standard Shipping |
| Unit Pricing | Pay-as-you-go | Continental US Overnight Shipping |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Cascade Cryobank product offering
Product offeringCore offering
Cascade Cryobank is a sperm bank that recruits, screens, and cryopreserves donor sperm specimens for sale to individuals, couples, and fertility clinics pursuing assisted reproduction. It offers five vial types differentiated by processing and cell count (IUI, ICI, IUI A.R.T., ICI A.R.T., IVF/ICSI), two donor identity disclosure programs (Open ID and the industry-first Early Disclosure Program), and supporting services including cold storage and FedEx shipping in temperature-controlled dry shippers.
Product overview
Cascade Cryobank is a sperm bank providing donor sperm for assisted reproductive care. The company operates a multi-product portfolio centered on cryopreserved sperm vials available in five distinct types (IUI, ICI, IUI A.R.T., ICI A.R.T., and IVF/ICSI), differentiated by processing level and cell count specifications. Two identity disclosure programs serve different transparency preferences: the proprietary Early Disclosure Program (industry-first allowing identity release at birth) and the standard Open ID Program (identity available at age 18). The Donor Catalog provides searchable access to screened donor profiles. Supporting services include fertility financing through a CapexMD partnership, temperature-controlled shipping, and cold storage with promotional free storage periods.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Only ~4% of sperm donor applicants are accepted into the program
- +2 more outcomes
Companies that use Cascade Cryobank
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles4 records
Cascade Cryobank technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cascade Cryobank partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- FertiocoreFertio, an international fertility care group and parent company of European Sperm Bank, acquired Cascade Cryobank in March 2026, marking its expansion into the U.S. market. The acquisition combines Fertio's 20+ years of global expertise with Cascade's Early Disclosure Program, setting new standards in the fertility industry.
- Canada CryobankminorPartnership with Canada Cryobank to share resources and expertise in donor screening and genetic screening, expanding reach and contributing to a more diverse donor pool while addressing growing demand for reproductive services.
- Monash IVFminorPartnership with Monash IVF, a leading fertility provider, to enhance reproductive health services through collaboration and shared expertise in sperm banking and fertility care.
- CapexMDminorPartnership with CapexMD, a specialized patient financing lender, to offer customized loan programs from $3,000 to $50,000 with competitive rates for fertility treatment financing. Loans can include medications and other needs with terms from 6 to 60 months.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Cascade Cryobank competitors and assessment
Company assessmentDirect peers
- Xytex: U.S. sperm bank offering IUI and ICI vials with detailed donor profiles and genetic screening. Comparable to Cascade in product structure and target customers, including LGBTQ+ family building and single parents by choice.
- European Sperm Bank: Fertio's flagship sperm bank and now sister brand to Cascade following the March 2026 acquisition. Comparable in product offering, screening standards, and identity disclosure options, and serves as the strategic backbone for Cascade's U.S. expansion.
- Fairfax Cryobank: One of the largest U.S. sperm banks, offering a similar portfolio of IUI/ICI/IVF vials with extensive donor screening and genetic testing. Directly comparable in product offering, target market, and clinic-facing distribution.
- Cryos International: The world's largest sperm bank with operations in the U.S. and internationally. Directly competes with Cascade across vial types, donor screening, and clinic/B2B coordination. Notably, Cascade's COO Corey Burke previously held executive roles at Cryos.
- The Sperm Bank of California: Nonprofit sperm bank known for early identity disclosure practices and an 'Identity-Release' donor program. Conceptually adjacent to Cascade's Early Disclosure Program and serves similar intended-parent segments on the West Coast.
- California Cryobank: Long-established U.S. sperm bank with a broad donor catalog, multi-state operations, and direct clinic and D2C channels. Closely comparable to Cascade in product mix, screening rigor, and target customer segments.
Regional players
- Seattle Sperm Bank: Pacific Northwest-based sperm bank with similar product portfolio and donor screening approach. Direct competitor in Cascade's home market, though Seattle Sperm Bank has a longer operating history and larger national footprint.
Broad incumbents
- Monash IVF: Major international fertility services group and a current Cascade partner. While broader in scope (full IVF clinical services rather than a pure sperm bank), it intersects with Cascade's value chain as both a customer and a clinical partner in the reproductive services ecosystem.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Cascade Cryobank social profiles
Digital presenceCascade Cryobank compliance and trust
Trust signalCompliance5 records
Cascade Cryobank financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cascade Cryobank leadership team
Management profileNumber of profiles
Profiles2 records
Cascade Cryobank funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cascade Cryobank M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cascade Cryobank
What does Cascade Cryobank do?
Cascade Cryobank is a sperm bank that recruits, screens, and cryopreserves donor sperm specimens for sale to individuals, couples, and fertility clinics pursuing assisted reproduction. It offers five vial types differentiated by processing and cell count (IUI, ICI, IUI A.R.T., ICI A.R.T., IVF/ICSI), two donor identity disclosure programs (Open ID and the industry-first Early Disclosure Program), and supporting services including cold storage and FedEx shipping in temperature-controlled dry shippers.
Is Cascade Cryobank a public or private company?
Cascade Cryobank is a private company. It is currently operating.
When was Cascade Cryobank founded?
Cascade Cryobank was founded in 2022. It employs 1 to 10 people.
Where is Cascade Cryobank based?
Cascade Cryobank is headquartered in Lynnwood, United States, in the North America region.
How does Cascade Cryobank make money?
Four revenue lines are on record. Donor Sperm Vial Sales are the primary driver. The others are specimen Storage, shipping and Delivery and sperm Donation Compensation.
Who are Cascade Cryobank's main competitors?
Direct peers on record are Xytex, European Sperm Bank, Fairfax Cryobank, Cryos International, The Sperm Bank of California and California Cryobank. Seattle Sperm Bank is listed as a regional player. Monash IVF is listed as a broad incumbent.
Does Cascade Cryobank have an API?
No public API is recorded for Cascade Cryobank.
What industry is Cascade Cryobank in?
Its primary akta.pro industry code is HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low), with a secondary code of HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies. Its NAICS code is 621991.